These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 27612194

  • 1. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR, Tsai CL, Huang YY, Shiue CY, Tzen KY, Yen RF, Hsin LW.
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [Abstract] [Full Text] [Related]

  • 2. Deuterated 18F-9-O-hexadeutero-3-fluoropropoxyl-(+)-dihydrotetrabenazine (D6-FP-(+)-DTBZ): A vesicular monoamine transporter 2 (VMAT2) imaging agent.
    Liu F, Choi SR, Zha Z, Ploessl K, Zhu L, Kung HF.
    Nucl Med Biol; 2018 Feb; 57():42-49. PubMed ID: 29306111
    [Abstract] [Full Text] [Related]

  • 3. An Efficient Automated Radiosynthesis and Bioactivity Confirmation of VMAT2 Tracer [18F]FP-(+)-DTBZ.
    Zhao C, Liu C, Tang J, Xu Y, Xie M, Chen Z.
    Mol Imaging Biol; 2020 Apr; 22(2):265-273. PubMed ID: 31165386
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of 10-(11) C-dihydrotetrabenazine as a vesicular monoamine transporter 2 radioligand.
    Li X, Chen Z, Tang J, Liu C, Zou P, Huang H, Tan C, Yu H.
    Arch Pharm (Weinheim); 2014 May; 347(5):313-9. PubMed ID: 24497196
    [Abstract] [Full Text] [Related]

  • 5. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters.
    Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF.
    Nucl Med Biol; 2006 Aug; 33(6):685-94. PubMed ID: 16934687
    [Abstract] [Full Text] [Related]

  • 6. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF.
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [Abstract] [Full Text] [Related]

  • 7. Derivatization of (±) dihydrotetrabenazine for copper-64 labeling towards long-lived radiotracers for PET imaging of the vesicular monoamine transporter 2.
    Kumar A, Lo ST, Öz OK, Sun X.
    Bioorg Med Chem Lett; 2014 Dec 15; 24(24):5663-5665. PubMed ID: 25467156
    [Abstract] [Full Text] [Related]

  • 8. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine.
    Koeppe RA, Frey KA, Kuhl DE, Kilbourn MR.
    J Cereb Blood Flow Metab; 1999 Dec 15; 19(12):1376-84. PubMed ID: 10598942
    [Abstract] [Full Text] [Related]

  • 9. [Quick and simple synthesis of (11)C-(+)-alpha-dihydrotetrabenazine to be used as a PET radioligand of vesicular monoamine transporters].
    Quincoces G, Collantes M, Catalán R, Ecay M, Prieto E, Martino E, Blesa FJ, Alvarez-Erviti L, Areses P, Arbizu J, Obeso JA, Martí-Climent JM, Richter JA, Peñuelas I.
    Rev Esp Med Nucl; 2008 Dec 15; 27(1):13-21. PubMed ID: 18208777
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain.
    Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, Kung MP, Kung HF.
    Nucl Med Biol; 2007 Apr 15; 34(3):233-7. PubMed ID: 17383572
    [Abstract] [Full Text] [Related]

  • 11. Lessons from 11C-dihydrotetrabenazine imaging in a xenograft mouse model of rat insulinoma: is PET imaging of pancreatic beta cell mass feasible?
    Collantes M, Barajas M, Quincoces G, Ramos-Membrive R, Martí-Climent JM, Ecay M, Rodríguez S, Escalada J, Peñuelas I.
    Q J Nucl Med Mol Imaging; 2017 Dec 15; 61(4):447-455. PubMed ID: 25881691
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of anesthetics on vesicular monoamine transporter type 2 binding to ¹⁸F-FP-(+)-DTBZ: a biodistribution study in rat brain.
    Chen Z, Tang J, Liu C, Li X, Huang H, Xu X, Yu H.
    Nucl Med Biol; 2016 Jan 15; 43(1):124-129. PubMed ID: 26526872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MicroPET imaging of vesicular monoamine transporter 2 revealed the potentiation of (+)-dihydrotetrabenazine on MPTP-induced degeneration of dopaminergic neurons.
    Xu Y, Tang J, Liu C, Zhao C, Cao S, Yu H, Chen Z, Xie M.
    Nucl Med Biol; 2021 Jan 15; 96-97():9-18. PubMed ID: 33647803
    [Abstract] [Full Text] [Related]

  • 17. PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ.
    Nag S, Jahan M, Tóth M, Nakao R, Varrone A, Halldin C.
    ACS Chem Neurosci; 2021 Dec 15; 12(24):4580-4586. PubMed ID: 34813272
    [Abstract] [Full Text] [Related]

  • 18. Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.
    Narendran R, Jedema HP, Lopresti BJ, Mason NS, Himes ML, Bradberry CW.
    Biol Psychiatry; 2015 Mar 01; 77(5):488-92. PubMed ID: 25062684
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of 3-alkyl-dihydrotetrabenazine derivatives as vesicular monoamine transporter-2 (VMAT2) ligands.
    Zheng P, Lieberman BP, Choi SR, Plöessl K, Kung HF.
    Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3435-8. PubMed ID: 21531556
    [Abstract] [Full Text] [Related]

  • 20. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans.
    Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ.
    Synapse; 2010 Jun 01; 64(6):417-20. PubMed ID: 20169578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.